NIH Reporter #PA-21-051

NIDDK Research Grant for Incretin-Mediated Beta Cell Response Studies

This opportunity is a research grant solicitation from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, focused on diabetes research. - Government Buyer: - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH - Products/Services Requested: - Research funding for studies investigating the mechanisms of incretin-mediated beta cell responses - No specific products, part numbers, or commercial equipment required - OEMs and Vendors: - No OEMs or commercial vendors are specified, as this is a grant for academic research - Notable Requirements: - Open to eligible research applicants using the standard NIH application process - Focus on incretin signaling mechanisms in beta cells, relevant to diabetes treatment - No unique licensing, classification, or liquidated damages requirements - Associated with the University of California at Davis, Yolo County, California - Estimated funding available is $32,536

Description

This is a research grant opportunity focused on incretin signaling mechanisms in beta cells, relevant to diabetes treatment research. The project aims to investigate the mechanisms driving the kinetics of incretin-mediated beta cell responses. The funding is provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The solicitation is open for applications with a standard NIH application format.

View original listing